Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-18-043906

Options or other derivatives

  • EVP, Head of R&D acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Seidel Ronald D. III EVP, Head of R&D 2018-07-23 Grant or award · Stock Option (right to buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…